Dna repair proteins associated with triple negative breast cancers and methods of use thereof
作者： Kam Marie Sprott , Xioazhe Wang , David T. Weaver
DOI:
关键词: Triple-negative breast cancer 、 Internal medicine 、 DNA repair 、 Triple negative 、 Oncology 、 Medicine
摘要: The present invention provides methods of detecting triple negative breast cancer recurrence using biomarkers.
lens.org 参考文章(9)
Charles L. Ginther, Edwin A. Clark, Judy Dering, Dennis J. Slamon, Richard S. Finn, Moesin, caveolin 1 and yes associated protein 1 as predictive markers of response to dasatinib in breast cancers ,(2006)
Valeria S. Ossovskaya, Barry M. Sherman, Method of treating diseases with parp inhibitors ,(2007)
Enrique Lerma, Gloria Peiro, Teresa Ramón, Sonia Fernandez, Daniel Martinez, Cristina Pons, Fina Muñoz, Josep Ma Sabate, Carmen Alonso, Belén Ojeda, Jaime Prat, Agustí Barnadas, Immunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2/neu (basal-like breast carcinomas). Modern Pathology. ,vol. 20, pp. 1200- 1207 ,(2007) , 10.1038/MODPATHOL.3800961
Emad A. Rakha, Maysa E. El-Sayed, Andrew R. Green, Andrew H. S. Lee, John F. Robertson, Ian O. Ellis, Prognostic markers in triple-negative breast cancer Cancer. ,vol. 109, pp. 25- 32 ,(2007) , 10.1002/CNCR.22381
Bhumsuk Keam, Seock-Ah Im, Hee-Jun Kim, Do-Youn Oh, Jee Hyun Kim, Se-Hoon Lee, Eui Kyu Chie, Wonshik Han, Dong-Wan Kim, Woo Kyung Moon, Tae-You Kim, In Ae Park, Dong-Young Noh, Dae Seog Heo, Sung Whan Ha, Yung-Jue Bang, None, Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer. BMC Cancer. ,vol. 7, pp. 203- 203 ,(2007) , 10.1186/1471-2407-7-203
Rahul R. Parikh, Qifeng Yang, Susan A. Higgins, Bruce G. Haffty, Outcomes in Young Women With Breast Cancer of Triple-Negative Phenotype: The Prognostic Significance of CK19 Expression International Journal of Radiation Oncology*Biology*Physics. ,vol. 70, pp. 35- 42 ,(2008) , 10.1016/J.IJROBP.2007.05.066
David S. P. Tan, Caterina Marchió, Robin L. Jones, Kay Savage, Ian E. Smith, Mitch Dowsett, Jorge S. Reis-Filho, Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients Breast Cancer Research and Treatment. ,vol. 111, pp. 27- 44 ,(2008) , 10.1007/S10549-007-9756-8
J Tommiska, J Bartkova, M Heinonen, L Hautala, O Kilpivaara, H Eerola, K Aittomäki, B Hofstetter, J Lukas, K von Smitten, C Blomqvist, A Ristimäki, P Heikkilä, J Bartek, H Nevanlinna, The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer. Oncogene. ,vol. 27, pp. 2501- 2506 ,(2008) , 10.1038/SJ.ONC.1210885
Alex Strongin, Stan Krajewski, Maryla Krajewski, Alexei Savinov, Methods related to mmp26 status as a diagnostic and prognostic tool in cancer management ,(2007)